Clinical Research
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 28, 2005; 11(44): 6988-6994
Published online Nov 28, 2005. doi: 10.3748/wjg.v11.i44.6988
Figure 1
Figure 1 Anti-Saccharomyces cerevisiae (A) IgG and (B) IgA antibody titers in ASCA-positive patients with Crohn’s disease expressed as a logarithmically (ln) scaled dilution unit of a highly positive control over a time-period of up to 3 years.